Stock ATHE ALTERITY THERAPEUTICS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Alterity Therapeutics Limited Nasdaq

Equities

ATHE

US02155X2053

Market Closed - Nasdaq
Other stock markets
 21:30:01 03/05/2024 BST 		5-day change 1st Jan Change
2.05 USD -4.21% Intraday chart for Alterity Therapeutics Limited -18.33% -17.67%
04-29 Alterity Therapeutics Limited Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Diseases CI
04-16 ADRs End Lower, Purple Biotech Ltd. Declines 29% DJ

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ladenburg Thalmann Initiates Alterity Therapeutics at Buy With $2 Price Target
MT
Goldman Sachs Adjusts Alterity Therapeutics' Price Target to $3 from $11, Keeps Neutral Rating
MT
Australian Shares Fall After US Fed Signals Earlier-than-Expected Rate Hike
MT
ALTERITY THERAPEUTICS : Benchmark Starts Alterity Therapeutics at Speculative Buy With $4 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ATH Stock
  4. ATHE Stock
  5. News Alterity Therapeutics Limited
  6. Analyst Reco.